Silverback Therapeutics' Series A - II Round

Silverback Therapeutics raised a round of funding on September 19, 2018.

Silverback Therapeutics is a Seattle, WA-based biotechnology company developing a pipeline of systemically delivered, locally active therapies that can be administered to patients but that act only at…

Articles about Silverback Therapeutics' Series A - II Round: